bioAffinity Technologies Statistics
Total Valuation
BIAF has a market cap or net worth of $7.32 million. The enterprise value is $1.01 million.
Important Dates
The last earnings date was Friday, November 14, 2025, before market open.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BIAF has 4.49 million shares outstanding. The number of shares has increased by 102.65% in one year.
| Current Share Class | 4.49M |
| Shares Outstanding | 4.49M |
| Shares Change (YoY) | +102.65% |
| Shares Change (QoQ) | +33.17% |
| Owned by Insiders (%) | 5.08% |
| Owned by Institutions (%) | 2.85% |
| Float | 4.02M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.18 |
| Forward PS | 1.18 |
| PB Ratio | 0.67 |
| P/TBV Ratio | 1.18 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.15 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.65, with a Debt / Equity ratio of 0.08.
| Current Ratio | 3.65 |
| Quick Ratio | 3.44 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -184.25 |
Financial Efficiency
Return on equity (ROE) is -245.18% and return on invested capital (ROIC) is -89.98%.
| Return on Equity (ROE) | -245.18% |
| Return on Assets (ROA) | -71.71% |
| Return on Invested Capital (ROIC) | -89.98% |
| Return on Capital Employed (ROCE) | -113.01% |
| Revenue Per Employee | $118,890 |
| Profits Per Employee | -$258,582 |
| Employee Count | 57 |
| Asset Turnover | 0.75 |
| Inventory Turnover | 161.36 |
Taxes
In the past 12 months, BIAF has paid $40,861 in taxes.
| Income Tax | 40,861 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -94.83% in the last 52 weeks. The beta is 2.42, so BIAF's price volatility has been higher than the market average.
| Beta (5Y) | 2.42 |
| 52-Week Price Change | -94.83% |
| 50-Day Moving Average | 2.32 |
| 200-Day Moving Average | 8.21 |
| Relative Strength Index (RSI) | 40.81 |
| Average Volume (20 Days) | 105,897 |
Short Selling Information
The latest short interest is 113,164, so 2.52% of the outstanding shares have been sold short.
| Short Interest | 113,164 |
| Short Previous Month | 109,788 |
| Short % of Shares Out | 2.52% |
| Short % of Float | 2.81% |
| Short Ratio (days to cover) | 0.11 |
Income Statement
In the last 12 months, BIAF had revenue of $6.78 million and -$14.74 million in losses. Loss per share was -$20.28.
| Revenue | 6.78M |
| Gross Profit | 1.89M |
| Operating Income | -10.38M |
| Pretax Income | -14.70M |
| Net Income | -14.74M |
| EBITDA | -9.85M |
| EBIT | -10.38M |
| Loss Per Share | -$20.28 |
Full Income StatementBalance Sheet
The company has $7.67 million in cash and $680,948 in debt, giving a net cash position of $6.99 million or $1.56 per share.
| Cash & Cash Equivalents | 7.67M |
| Total Debt | 680,948 |
| Net Cash | 6.99M |
| Net Cash Per Share | $1.56 |
| Equity (Book Value) | 8.90M |
| Book Value Per Share | 2.57 |
| Working Capital | 6.25M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$8.45 million and capital expenditures -$60,568, giving a free cash flow of -$8.51 million.
| Operating Cash Flow | -8.45M |
| Capital Expenditures | -60,568 |
| Free Cash Flow | -8.51M |
| FCF Per Share | -$1.89 |
Full Cash Flow StatementMargins
Gross margin is 27.86%, with operating and profit margins of -153.20% and -217.50%.
| Gross Margin | 27.86% |
| Operating Margin | -153.20% |
| Pretax Margin | -216.89% |
| Profit Margin | -217.50% |
| EBITDA Margin | -145.31% |
| EBIT Margin | -153.20% |
| FCF Margin | n/a |